Catalent to manufacture Verastem's US FDA-approved oncology treatment
Oncology drug Copiktra was developed during a multi-year collaboration between Catalent Pharma and Verastem Oncology.
Archives for October 29, 2018
Researchers test ‘the very premise of precision medicine,’ the future of trial design
A proof-of-concept study using patient-derived cells to test drug response in clinical trials demonstrates the benefits of precision medicine, movement to which is the future of study design, says researcher.
CDMO Idifarma wins Palobiofarma contract for clinical trials
Idifarma’s seventh project with Palobiofarma will see the CDMO provide drug formulation, development and manufacturing services for respiratory disease candidate PBF-2987.
Report: US FDA guidance on complex generics to boost ANDAs in India
The FDA’s recent guidance on complex generics ‘increases clarity’ for Indian drugmakers targeting the US market, according to India Ratings and Research.
Icon reports record awards in Q3, outlines 3-part patient recruitment strategy
Icon reported a record number of new business awards in Q3 and outlined its three-part patient recruitment strategy as well as global hiring – and acquiring – plans.
2018: The year that pharma got its house in order
This year a number of companies made big moves to divest certain parts of their portfolios, but why has it been such a significant year for this?